VIC Portfolio Companies and Pipeline Technologies with Pandemic Impact

Our current daily activities bear little resemblance to the routines as of as recently as a month ago. COVID-19 has had an obvious and significant impact on the American people. For those suffering from chronic...

From The Corner Office: SFC Fluidics Nears FDA Submission

“Did you eat too much candy as a child?” “You don’t look diabetic…you are not at all overweight.” “You just have to watch your sugar intake, right?” These are typical, insensitive comments that people with diabetes...

VIC Technology Venture Development Forms New Portfolio Company: Neurexis Therapeutics

Neurexis Therapeutics, Inc. to develop a new medication for the prevention of brain damage following ischemic events such as stroke

VIC Launches New Fellows Program

The VIC Fellows Program was created as a mechanism through which individuals with specific expertise can learn about and be involved in the process of identifying and evaluating promising life science innovation from...

VIC Technology Venture Development Forms New Portfolio Company: Filtravate

Company co-founded with Reza Foudazi, PhD, developer of a platform membrane technology with broad applications in bioprocessing and industrial filtration.

Failing to fundraise can be the downfall of startups

Startups are pulling outsized financing rounds and debt acquisitions at an unprecedented rate despite the high 80 percent failure rate of startups overall. Among the three primary reasons why startups tend to fail,...

An Interview with Darlene Boudreaux: CEO, Investor, and Entrepreneur

Can you tell us a little bit about your background and experience? I was a founder and CEO of a pharmaceutical manufacturing company, and then took over and grew a nonprofit medical technology incubator, helping others...

VIC 2019 Annual Report

In the past year, VIC’s portfolio of companies reached numerous milestones, the VIC Investor Network (VIN) experienced its first exit, and we added important new elements to the VIC ecosystem. While progress in 2019 was...

Behind the Curtain with Biolocity | Guiding Medical Innovations to Market

Please start off by describing your current role with Biolocity and the organization’s unique model. I am the Managing Director for Biolocity, which is a philanthropic, multi-institutional program that accelerates the...

White Paper: New Paradigms of Life Science Investing

For decades, only venture capital (VC) firms, and very rarely, angels were able to invest in start-up companies developing life science—therapeutics, medical devices, diagnostics, and related—innovation. Anyone doing so...

FEATURED RESOURCES

Updates
VIC Tech Announces New Class of Fellows
Insight
Our Life Science and Healthcare Future
White Paper
Portfolio Diversification in Times of Market Volatility
Interview
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
Insight
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity
News
Nob Hill Therapeutics Secures Series A Funding to Advance Breakthrough Respiratory Technologies
Interview
VIC Fellows Spotlight: Matthew Leming, PhD
From The Corner Office
From the Corner Office: Zebra Analytix